Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is hepatitis C virus a risk factor for thyroid autoimmunity?

A Floreani1, C Betterle, I Carderi

  • 1Department of Surgical and Gastroenterological Sciences, University of Padova, Italy. annarosa.floreani@unipd.it

Journal of Viral Hepatitis
|April 14, 2006
PubMed
Summary

Hepatitis C virus (HCV) infection does not appear to cause thyroid autoimmunity. However, HCV infection is linked to an increase in nonorgan-specific autoantibodies (NOSAs), suggesting a broader impact on the immune system.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.

Journal of endocrinological investigation·2023
Same author

Correction to: A non-classical presentation of APECED in a family with heterozygous R203X AIRE gene mutation.

Journal of endocrinological investigation·2022
Same author

A non-classical presentation of APECED in a family with heterozygous R203X AIRE gene mutation.

Journal of endocrinological investigation·2022
Same author

Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency.

Journal of endocrinological investigation·2022
Same author

Sex disparity and drug-induced liver injury.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2022

Area of Science:

  • Immunology
  • Hepatology
  • Endocrinology

Background:

  • The link between Hepatitis C virus (HCV) infection and thyroid autoimmunity remains unclear.
  • Assessing the prevalence of thyroid autoantibodies and disease in the general population is crucial.
  • Understanding HCV's role in autoimmune conditions requires comprehensive population studies.

Purpose of the Study:

  • To determine the prevalence of thyroid autoantibodies and thyroid disease in a general population.
  • To analyze the specific role of HCV infection in the development of thyroid autoimmunity.
  • To investigate the association between HCV and nonorgan-specific autoantibodies (NOSAs).

Main Methods:

  • A study of 697 individuals from Arsita, central Italy.
  • Screening for anti-HCV antibodies and HCV-RNA to identify infected subjects.

Related Experiment Videos

  • Testing for thyroid autoantibodies, nonorgan-specific autoantibodies (NOSAs), and thyroid function.

    • Main Results:

    • No significant difference in thyroid autoantibody prevalence was found between HCV-positive (5.6%) and HCV-negative (4.9%) individuals.
    • Thyroid dysfunction rates were similar in both HCV-positive and HCV-negative subjects with thyroid autoantibodies.
    • Nonorgan-specific autoantibodies (NOSAs) were significantly more prevalent in HCV-positive subjects (P < 0.0001).

    Conclusions:

    • Hepatitis C virus (HCV) infection is not directly responsible for thyroid autoimmune dysfunction.
    • HCV infection appears to induce nonorgan-specific autoantibodies (NOSAs).
    • Factors like genetic predisposition, sex, and other infections influence autoimmune disease expression.